CF
CRBP icon

Corebridge Financial’s Corbus Pharmaceuticals CRBP Stock Holding History

Corebridge Financial’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,772
Closed -$30.6K – 645
2025
Q1 		$30.6K Sell
5,772
-20
-0.3% -$177 ﹤0.01% 2833
2024
Q4 		$68.3K Buy
5,792
+265
+5% +$4.44K ﹤0.01% 2732
2024
Q3 		$114K Buy
5,527
+60
+1% +$3.07K ﹤0.01% 2552
2024
Q2 		$247K Buy
+5,467
New +$230K ﹤0.01% 2067

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Corebridge Financial's CRBP Position: Q2 2025 in Review

Corebridge Financial sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 5,772 shares — an estimated $30.6K sold.

Corebridge Financial first reported a position in CRBP in Q2 2024 and held it in 4 quarters. The position peaked at $247K in Q2 2024. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Corebridge Financial reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 5,772 Corbus Pharmaceuticals shares in Q2 2025, an estimated $30.6K.
  • Corebridge Financial first reported a position in Corbus Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Corbus Pharmaceuticals position peaked at $247K in Q2 2024.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.